OSI Pharmaceuticals' P2P Acquisition

OSI Pharmaceuticals raised a round of funding on June 09, 2010. Investors include Astellas Pharma.

OSI Pharmaceuticals is a biotechnology company primarily focused on the discovery, development, and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes, an…

Articles about OSI Pharmaceuticals' P2P Acquisition: